Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 2
1979 4
1980 5
1981 9
1982 8
1983 7
1984 2
1985 12
1986 4
1987 4
1988 1
1989 3
1990 8
1991 2
1992 6
1993 5
1994 7
1995 11
1996 7
1997 12
1998 3
1999 8
2000 9
2001 3
2002 5
2003 3
2004 4
2005 7
2006 2
2007 9
2008 8
2009 6
2010 5
2011 10
2012 10
2013 6
2014 7
2015 4
2016 6
2017 7
2018 10
2019 7
2020 8
2021 6
2022 4
2023 1
2024 1
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

260 results

Results by year

Filters applied: . Clear all
Page 1
Integrated genomic characterization of oesophageal carcinoma.
Cancer Genome Atlas Research Network; Analysis Working Group: Asan University; BC Cancer Agency; Brigham and Women’s Hospital; Broad Institute; Brown University; Case Western Reserve University; Dana-Farber Cancer Institute; Duke University; Greater Poland Cancer Centre; Harvard Medical School; Institute for Systems Biology; KU Leuven; Mayo Clinic; Memorial Sloan Kettering Cancer Center; National Cancer Institute; Nationwide Children’s Hospital; Stanford University; University of Alabama; University of Michigan; University of North Carolina; University of Pittsburgh; University of Rochester; University of Southern California; University of Texas MD Anderson Cancer Center; University of Washington; Van Andel Research Institute; Vanderbilt University; Washington University; Genome Sequencing Center: Broad Institute; Washington University in St. Louis; Genome Characterization Centers: BC Cancer Agency; Broad Institute; Harvard Medical School; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University; University of North Carolina; University of Southern California Epigenome Center; University of Texas MD Anderson Cancer Center; Van Andel Research Institute; Genome Data Ana… See abstract for full author list ➔ Cancer Genome Atlas Research Network, et al. Nature. 2017 Jan 12;541(7636):169-175. doi: 10.1038/nature20805. Epub 2017 Jan 4. Nature. 2017. PMID: 28052061 Free PMC article.
Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation.
O'Reilly EM, Lee JW, Zalupski M, Capanu M, Park J, Golan T, Tahover E, Lowery MA, Chou JF, Sahai V, Brenner R, Kindler HL, Yu KH, Zervoudakis A, Vemuri S, Stadler ZK, Do RKG, Dhani N, Chen AP, Kelsen DP. O'Reilly EM, et al. Among authors: kelsen dp. J Clin Oncol. 2020 May 1;38(13):1378-1388. doi: 10.1200/JCO.19.02931. Epub 2020 Jan 24. J Clin Oncol. 2020. PMID: 31976786 Free PMC article. Clinical Trial.
First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial.
Janjigian YY, Maron SB, Chatila WK, Millang B, Chavan SS, Alterman C, Chou JF, Segal MF, Simmons MZ, Momtaz P, Shcherba M, Ku GY, Zervoudakis A, Won ES, Kelsen DP, Ilson DH, Nagy RJ, Lanman RB, Ptashkin RN, Donoghue MTA, Capanu M, Taylor BS, Solit DB, Schultz N, Hechtman JF. Janjigian YY, et al. Among authors: kelsen dp. Lancet Oncol. 2020 Jun;21(6):821-831. doi: 10.1016/S1470-2045(20)30169-8. Epub 2020 May 18. Lancet Oncol. 2020. PMID: 32437664 Free PMC article. Clinical Trial.
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival.
Varghese AM, Perry MA, Chou JF, Nandakumar S, Muldoon D, Erakky A, Zucker A, Fong C, Mehine M, Nguyen B, Basturk O, Balogun F, Kelsen DP, Brannon AR, Mandelker D, Vakiani E, Park W, Yu KH, Stadler ZK, Schattner MA, Jarnagin WR, Wei AC, Chakravarty D, Capanu M, Schultz N, Berger MF, Iacobuzio-Donahue CA, Bandlamudi C, O'Reilly EM. Varghese AM, et al. Among authors: kelsen dp. Nat Med. 2025 Feb;31(2):466-477. doi: 10.1038/s41591-024-03362-3. Epub 2025 Jan 3. Nat Med. 2025. PMID: 39753968 Free PMC article.
Reply to N. Fazio.
O'Reilly EM, Park W, Kelsen DP. O'Reilly EM, et al. Among authors: kelsen dp. J Clin Oncol. 2020 Jul 20;38(21):2467-2468. doi: 10.1200/JCO.20.00833. Epub 2020 May 14. J Clin Oncol. 2020. PMID: 32407214 Free PMC article. No abstract available.
Genomic dysregulation in gastric tumors.
Janjigian YY, Kelsen DP. Janjigian YY, et al. Among authors: kelsen dp. J Surg Oncol. 2013 Mar;107(3):237-42. doi: 10.1002/jso.23263. Epub 2012 Oct 5. J Surg Oncol. 2013. PMID: 23042588 Review.
Chemotherapy in esophageal cancer.
Enzinger PC, Ilson DH, Kelsen DP. Enzinger PC, et al. Among authors: kelsen dp. Semin Oncol. 1999 Oct;26(5 Suppl 15):12-20. Semin Oncol. 1999. PMID: 10566606 Review.
Adjuvant treatment of colorectal cancer.
Saltz LB, Kelsen DP. Saltz LB, et al. Among authors: kelsen dp. Annu Rev Med. 1997;48:191-202. doi: 10.1146/annurev.med.48.1.191. Annu Rev Med. 1997. PMID: 9046955 Review.
260 results